Home > Compound List > Product Information
Trapidil_Molecular_structure_CAS_15421-84-8)
Click picture or here to close

Trapidil

Catalog No. SML0071 Name Sigma Aldrich
CAS Number 15421-84-8 Website http://www.sigmaaldrich.com
M. F. C10H15N5 Telephone 1-800-521-8956
M. W. 205.2596 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 155063

SYNONYMS

IUPAC name
N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
IUPAC Traditional name
trapidil
Synonyms
Trapymine
Trapymin
Rocornal
AR 12008
Avantrin
N,N-diethyl-5-methyl-[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine

DATABASE IDS

EC Number 239-434-2
MDL Number MFCD00193104
CAS Number 15421-84-8

PROPERTIES

Empirical Formula (Hill Notation) C10H15N5
Purity ≥98% (HPLC)
Apperance white to tan powder
Solubility H2O: ≥15 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Trapidil is an antiplatelet agent that acts in part as a phosphodiesterase inhibitor and as a competitive inhibitor of the platelet-derived growth factor (PDGF) receptor. Trapidil, with its vasodilator and NO releasing effect may have some potential to diminish the tissue injury. Trapidil suppresses platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell (VSMC) proliferation by inhibiting Raf-1/extracellular signal-regulated kinase (ERK) via cAMP/protein kinase A (PKA). In addn. to cAMP/PKA activation, trapidil inhibits RhoA/ROCK activation.
Description (简体中文)
Biochem/physiol Actions
Trapidil is an antiplatelet agent that acts in part as a phosphodiesterase inhibitor and as a competitive inhibitor of the platelet-derived growth factor (PDGF) receptor. Trapidil, with its vasodilator and NO releasing effect may have some potential to diminish the tissue injury. Trapidil suppresses platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell (VSMC) proliferation by inhibiting Raf-1/extracellular signal-regulated kinase (ERK) via cAMP/protein kinase A (PKA). In addn. to cAMP/PKA activation, trapidil inhibits RhoA/ROCK activation.

REFERENCES